Karyopharm Therapeutics Inc (KPTI)

04:13 AM

Karyopharm Therapeutics (KPTI) director receives 15,508 RSUs in equity award - Stock Titan

04:13 AM

04:12 AM

Karyopharm (KPTI) director receives 15,508 RSU equity award vesting in 2027 - Stock Titan

04:12 AM

04:06 AM

Karyopharm (NASDAQ: KPTI) director gets 15,508 RSUs vesting in 2027 - Stock Titan

04:06 AM

08:04 AM

Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts - Yahoo Finance

08:04 AM

07:06 AM

Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus - Yahoo Finance

07:06 AM

May 24, 2026

KPTI PE Ratio & Valuation, Is KPTI Overvalued - Intellectia AI

May 24, 2026

May 22, 2026

KPTI Stock Price, Quote & Chart | KARYOPHARM THERAPEUTICS INC (NASDAQ:KPTI) - ChartMill

May 22, 2026

May 20, 2026

Karyopharm rises on securing $100M in financing to extend cash runway into Q2 2026 - MSN

May 20, 2026

May 20, 2026

KPTI Technical Analysis | Trend, Signals & Chart Patterns | KARYOPHARM THERAPEUTICS INC (NASDAQ:KPTI) - ChartMill

May 20, 2026

May 20, 2026

Karyopharm (KPTI) Leans on SENTRY in Pivotal Call - TipRanks

May 20, 2026

May 20, 2026

Earnings call transcript: Karyopharm Q1 2026 results disappoint, stock drops By Investing.com - Investing.com Australia

May 20, 2026

May 20, 2026

Earnings call transcript: Karyopharm Q1 2026 results disappoint, stock drops - Investing.com UK

May 20, 2026

May 17, 2026

Karyopharm Therapeutics (KPTI) price target increased by 13.33% to 13.87 - MSN

May 17, 2026

May 17, 2026

Karyopharm shares rise 10% after mixed Phase 3 SENTRY trial results - MSN

May 17, 2026

May 17, 2026

Karyopharm Therapeutics Inc.Common Stock (NQ: KPTI - FinancialContent

May 17, 2026

May 16, 2026

RBC Capital Remains a Buy on Karyopharm Therapeutics (KPTI) - The Globe and Mail

May 16, 2026

May 15, 2026

Opaleye Management Inc. Reduces Stake in Karyopharm Therapeutics Inc. - GuruFocus

May 15, 2026

May 15, 2026

Ikarian Capital (KPTI) files joint 13G showing sub‑5% holding - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm Therapeutics CAO Kristin Abate sells $503 in stock By Investing.com - Investing.com South Africa

May 15, 2026

May 15, 2026

Karyopharm Therapeutics CAO Kristin Abate sells $503 in stock - Investing.com

May 15, 2026

May 15, 2026

Karyopharm (KPTI) EVP nets PSUs, then small tax-driven share sale - Stock Titan

May 15, 2026

May 15, 2026

[Form 4] Karyopharm Therapeutics Inc. Insider Trading Activity - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm (KPTI) EVP earns PSU shares, sells 324 to cover taxes - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm (KPTI) CAO reports PSU vesting and small pre-planned tax sale - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm (KPTI) CEO logs PSU vesting and automatic tax-related share sale - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm (KPTI) EVP sale covers tax on earned PSU award - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm (KPTI) Schedule 13G: Acorn entities and Anders Hove report 1.52M shares - Stock Titan

May 15, 2026

May 15, 2026

RBC Capital Maintains Karyopharm Therapeutics(KPTI.US) With Buy Rating, Maintains Target Price $16 - Moomoo

May 15, 2026

May 15, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2026 Earnings Call Transcript - Insider Monkey

May 15, 2026

May 15, 2026

[EFFECT] Karyopharm Therapeutics Inc. SEC Filing - Stock Titan

May 15, 2026

May 15, 2026

Karyopharm Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript - Sahm

May 15, 2026

May 14, 2026

Karyopharm Therapeutics 1Q Loss/Shr $1.24 >KPTI - Moomoo

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Inc (KPTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Inc (KPTI) Q1 2026 Earnings Call Highlig - GuruFocus

May 14, 2026

May 14, 2026

Karyopharm Earnings Call: Trial Wins, Cash Questions - TipRanks

May 14, 2026

May 14, 2026

Earnings Call Summary | Karyopharm Therapeutics(KPTI.US) Q1 2026 Earnings Conference - 富途牛牛

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Inc (KPTI) Stock Price, Quote, News & History - Benzinga

May 14, 2026

May 14, 2026

KPTI Projects 2026 Revenue Between $130M and $150M - GuruFocus

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 14, 2026

May 14, 2026

Karyopharm Therapeutics (KPTI) Reports Strong Q1 Earnings, Beats Expectations - GuruFocus

May 14, 2026

May 14, 2026

Affinity Asset Advisors reports 2.07M shares in Karyopharm (KPTI) - Stock Titan

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Inc. Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Releases Q1 2026 Financial Results - AlphaStreet

May 14, 2026

May 14, 2026

Karyopharm (KPTI) Q1 2026 Earnings Transcript - AOL.com

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Q1 Earnings Call Highlights - Yahoo Finance

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat

May 14, 2026

May 14, 2026

Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer - Minichart

May 14, 2026

May 14, 2026

Is Karyopharm Therapeutics (KPTI) Overvalued After Q1 2026 Earni - GuruFocus

May 14, 2026

May 14, 2026

Earnings call transcript: Karyopharm sees revenue growth, stock rises in Q1 2026 - Investing.com Nigeria

May 14, 2026

May 14, 2026

Earnings call transcript: Karyopharm sees revenue growth, stock rises in Q1 2026 By Investing.com - Investing.com South Africa

May 14, 2026

May 14, 2026

KPTI: Strong Q1 revenue, compelling SENTRY data, and solid liquidity position support 2026 outlook - TradingView

May 14, 2026

May 14, 2026

KPTI Outlines Promising Growth Potential Following Q1 Revenue Su - GuruFocus

May 14, 2026

May 14, 2026

KPTI: Strong Q1 revenue, positive SENTRY trial results, and robust commercial outlook for 2026 - TradingView

May 14, 2026

May 14, 2026

Karyopharm Therapeutics sets near term milestones in cancer and myelofibrosis pipelines after Q1 update - Traders Union

May 14, 2026

May 14, 2026

Karyopharm completes endometrial cancer trial enrollment - Investing.com UK

May 14, 2026